Clinical manifestations and management of neurofibromatosis type 1.
about
Emerging pharmacotherapies for neurodevelopmental disordersA Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.Neurofibromatosis: chronological history and current issues.Twenty questions in genetic medicine--an assessment of World Wide Web databases for genetics information at the point of care.Diffuse intestinal ganglioneuromatosis in a child.A large intrathoracic meningocele in a patient with neurofibromatosis-1Plexiform neurofibroma treated with pharmacopunctureValosin-containing protein and neurofibromin interact to regulate dendritic spine densitySocial-emotional functioning of children and adolescents with neurofibromatosis type 1 and plexiform neurofibromas: relationships with cognitive, disease, and environmental variables.Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1.126 novel mutations in Italian patients with neurofibromatosis type 1.Posterolateral inter-transverse lumbar fusion in a mouse model.Abnormal relationship between GABA, neurophysiology and impulsive behavior in neurofibromatosis type 1.CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors.Distribution and Within-Family Specificity of Quantitative Autistic Traits in Patients with Neurofibromatosis Type I.Modeling cognitive dysfunction in neurofibromatosis-1Monogenic vessel diseases related to ischemic stroke: a clinical approach.Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1.Vulvar malignancy in neurofibromatosis syndromeGiant Intrathoracic Meningocele and Breast Cancer in a Neurofibromatosis Type I Patient.A Giant Lumbar Pseudomeningocele in a Patient with Neurofibromatosis Type 1: A Case ReportApplication of the International Classification of Functioning, Disability and Health in children with neurofibromatosis type 1: a review.Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with neurofibromatosis type 1: a systematic reviewNeurofibromatosis type 1 and attention deficit hyperactivity disorder: a case study and literature reviewTargeting group I p21-activated kinases to control malignant peripheral nerve sheath tumor growth and metastasis.Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas.The Role of [18F]FDG-PET/CT in Predicting Malignant Transformation of Plexiform Neurofibromas in Neurofibromatosis-1.Neurofibromatosis Clinic: A Report on Patient Demographics and Evaluation of the Clinic.Attitudes about internet support groups among adolescents and young adults with neurofibromatosis type 1 and their parents.Sustained inhibition of receptor tyrosine kinases and macrophage depletion by PLX3397 and rapamycin as a potential new approach for the treatment of MPNSTs.Lady with wings: a case report of giant neurofibromatosis type IMultivariate pattern analysis reveals subtle brain anomalies relevant to the cognitive phenotype in neurofibromatosis type 1.Novel in-frame deletion mutation c.177_179delTAC of neurofibromatosis type 1 in a Chinese 4-year-old boy with binocular blindness.Expression profiling of 519 kinase genes in matched malignant peripheral nerve sheath tumor/plexiform neurofibroma samples is discriminatory and identifies mitotic regulators BUB1B, PBK and NEK2 as overexpressed with transformation.Large intrathoracic meningocele in a patient with neurofibromatosis type 1.Malignant peripheral nerve sheath tumor in children: A single-institute retrospective analysis.Psychosocial Features of Neurofibromatosis Type 1 in Children and Adolescents.Feasibility and Preliminary Efficacy of an Internet Support Group for Parents of a Child with Neurofibromatosis Type 1: a Pilot Study.PedsQL Neurofibromatosis Type 1 Module for children, adolescents and young adults: feasibility, reliability, and validity.Do the nodules detected in chest X-rays always indicate a disease of lung parenchyma?
P2860
Q24619170-9CD3759E-83CA-4F51-8ADC-767B52E0B682Q30252766-33DFFDD0-BA31-44D8-A51D-85B9FCB124DEQ30449267-12686EFF-72BC-4E77-B073-414124DC477BQ30483973-CCF69CDF-AC9A-40B7-AF83-13F3375A822DQ33828134-87D0289A-C569-4FD5-B509-DD1CAB420A7CQ33893980-92520461-02ED-4178-A6D4-557A19333C42Q35093743-9A50D7FC-25EC-488A-A181-7ED106ED8550Q35578562-DC6DC354-D640-4D83-A073-437E1F498831Q36114344-0B6AC92C-562B-4FF5-893F-746337627CB7Q36243945-5F927499-AB3F-4599-B537-103600B2D6BCQ36411302-F83C2F16-010C-4346-844C-1034B4FD894BQ36588552-6EFF7E4B-B4B6-4EED-A7C8-E1CDEF43BC3DQ36648986-0CDA197C-3E17-4578-95A5-129D5B002B4EQ36675171-E2FB1A00-3C0B-4635-B0E9-B0F45B405CE1Q36688215-92B5B46B-755B-4989-93BE-A6444304EB61Q36756183-12736046-AB32-40D5-8C12-254EDFE2CFA9Q36853643-5756B8C6-A539-4607-B86A-D662C323C7E1Q37151995-9A4B6271-8B4C-4E7B-8535-85CADFC5A41BQ37220286-9AA1436B-EA8D-4172-9EAE-88ABE17FAD33Q37409935-1D1F4DF5-29F1-4AF8-9FAC-02A8E6597056Q37640039-6AF6D444-51B0-49BE-8987-DEC252FBB225Q37699438-6DBBBF97-114F-49E5-BC00-BFE25B454DBFQ38044728-5331877B-DB1C-49A2-857B-E06384108FE8Q38408760-4337AF2E-3AC1-47AD-85E6-4F56E7EEA524Q38769437-B4F14044-4D6C-4E42-82F5-E3E870C92E81Q38890111-0169B918-33B6-4904-8051-201CF515C765Q39037132-80583B80-A24A-4AA5-88F7-5B8D2E575A79Q39207965-B3C7E94B-83E8-4EF2-8BEB-5EDBF23C958CQ39262537-30C3F9C7-0C87-4116-8180-0D77DB871464Q40804607-FEEA8178-48FF-406E-B221-348D855E11C9Q41091003-336BC13A-2907-4D0E-8514-2AC195674AB5Q42512482-6C443D12-99D4-438C-A432-3178667300EFQ43191047-71575BFC-D595-462B-8C56-970FFE874361Q46083335-ECCFD559-E691-42A6-A9B2-1D1E6B14E0C3Q46323202-2FE0CD01-FB40-489E-BF03-E73936605006Q47183302-68E94940-3A74-41D1-A298-E5743074AB2FQ47557393-2748EF44-3532-4743-A7FF-7AB2C09D775EQ48036748-1EA2A80C-8A2D-44E4-86B0-3489EB70A2BBQ48353369-15B3383A-B31A-424A-8AC7-A670BE8C2334Q48358886-3069D2B1-0892-4391-8782-90DD8F51BEBF
P2860
Clinical manifestations and management of neurofibromatosis type 1.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Clinical manifestations and management of neurofibromatosis type 1.
@ast
Clinical manifestations and management of neurofibromatosis type 1.
@en
type
label
Clinical manifestations and management of neurofibromatosis type 1.
@ast
Clinical manifestations and management of neurofibromatosis type 1.
@en
prefLabel
Clinical manifestations and management of neurofibromatosis type 1.
@ast
Clinical manifestations and management of neurofibromatosis type 1.
@en
P1476
Clinical manifestations and management of neurofibromatosis type 1.
@en
P2093
James H Tonsgard
P356
10.1016/J.SPEN.2006.01.005
P577
2006-03-01T00:00:00Z